A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine

@article{Fleishaker2004APA,
  title={A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine},
  author={J. Fleishaker and L. K. Hulst},
  journal={European Journal of Clinical Pharmacology},
  year={2004},
  volume={46},
  pages={35-39}
}
  • J. Fleishaker, L. K. Hulst
  • Published 2004
  • Medicine
  • European Journal of Clinical Pharmacology
  • We have assesed the pharmacokinetic and pharmacodynamic interaction between fluvoxamine, a serotonin reuptake inhibitor, and alprazolam, a triazolobenzodiazepine.Healthy men took fluvoxamine maleate daily for 10 days (50 mg on days 1–3, 100 mg on days 4–10) (n=20), 1 mg of alprazolam four times daily for four days (days 7–10 of the study period) (n=20), or a combination of the two (n=20), according to a parallel study design. Alprazolam and fluvoxamine concentrations were measured in serial… CONTINUE READING

    Figures, Tables, and Topics from this paper.

    The effect of fluvoxamine on the pharmacokinetics and pharmacodynamics of buspirone
    • 34
    • Highly Influenced
    Minimal interaction between fluoxetine and multiple-dose zolpidem in healthy women.
    • 21
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 19 REFERENCES
    Clinical Pharmacokinetics of Alprazolam
    • 129
    Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    • 469
    • Highly Influential
    • PDF
    Clinical Pharmacokinetics of Selective Serotonin Reuptake Inhibitors
    • 227
    • Highly Influential
    Determination of clovoxamine concentration in human plasma by electron capture gas chromatography.
    • 23
    • PDF